跳至主要内容
临床试验/NCT00824837
NCT00824837已完成1 期

Randomised, Cross Over Pilot Study Comparing Removal of beta2-Microglobulin by Standard Haemodialysis to Haemodialysis With a Novel Dialysis Membrane (P2SH) in Chronic Dialysis Patients

Austin Health2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
Austin Health
入组人数
8
试验地点
2
主要终点
Beta2-microglobulin removal by new larger pore membrane versus standard haemodialysis membrane

研究概览

简要总结

The purpose of this study is to determine whether a novel haemodialysis membrane, compared with the standard dialysis membrane, will increase the removal of beta2-microglobulin in chronic dialysis patients.

详细描述

Despite advances in treatment of kidney diseases, morbidity and mortality of chronic dialysis patients remains unsatisfactory. Standard haemodialysis membranes remove middle-sized molecule solutes poorly such as beta2-microglobulin, which has a pathogenic role in dialysis-related amyloidosis. Pre-dialysis beta2-microglobulin concentration has been shown to be independently predictive of mortality. A new polyamide haemodialysis membrane has been developed with increased pore size to increase the removal of middle-sized uraemic toxins such as beta2-microglobulin. This study aims to evaluate the effectiveness of the new membrane in beta2-microglobulin removal compared with standard haemodialysis membrane in dialysis patients and the degree of increased loss of albumin as a potential limiting factor of its use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic haemodialysis patients for more than 2 years
  • Urine output <100 mL per day
  • 3 haemodialysis sessions per week
  • Permanent arteriovenous dialysis access

排除标准

  • Serum albumin <25 g/L

结局指标

主要结局

Beta2-microglobulin removal by new larger pore membrane versus standard haemodialysis membrane

时间窗: 5 weeks (2 weeks in each arm, 1-week washout period)

次要结局

  • Albumin loss with the use of new larger pore membrane compared with standard haemodialysis membrane(5 weeks (2 weeks in each arm, 1-week washout period))
  • Removal of low-molecular-weight solutes by new larger pore membrane versus standard haemodialysis membrane(5 weeks (2 weeks in each arm; 1-week washout period))

研究者

发起方
Austin Health
申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验

Study of beta2-Microglobulin Removal by Standard... | 临床试验